EVENT / PUBLIC SOURCE RECORD
Norway: Shaping the future of radiopharmaceuticals
- Networking seminar/reception held 17 April 2026, 17:30–19:30 (GMT+01:00), in Bergen. The page presents Norway as an integrated radiopharmaceutical innovation hub spanning research, clinical capability, and industrial-scale manufacturing, and says the reception was supported by the Research Council of Norway.
- The event was intended to connect stakeholders from Norwegian research and academia and explain expertise in nuclear medicine, chemistry, and oncology, as well as preclinical/clinical infrastructure and access to national trial environments. Topics included commercial radiopharmaceutical production, nuclear-medicine handling and logistics, the integrated research-to-manufacturing value chain, closing remarks by Dimitrios Mantzilas of Actithera, and informal networking with refreshments.
- Partners: Innovation Norway, NorTrials, the Norwegian Pharmaceutical Industry (LMI), University of Bergen, and Helse Bergen. Contacts: Signe Øien Fretland, Head of NorTrials coordinating unit (sigfre@ous-hf.no), and Monica Larsen, Senior Advisor at LMI (monica@lmi.no). Related industry: health and life science. The page links to the radiopharma industry page, an article about Norway’s role in alpha therapy, and a related ESRR 2026 event.